Biktarvy Approved to Treat Pediatric Patients With HIV-1
[From Monthly Prescribing Reference, June 19, 2019] “The Food and Drug Administration (FDA) has approved updated labeling for Biktarvy (bictegravir, emtricitabine, and tenofovir alafenamide; Gilead) to include treatment of both adult and pediatric patients weighing at least 25kg with HIV-1 who have no antiretroviral treatment history or to replace the current antiretroviral regimen in those […]
Biktarvy Approved to Treat Pediatric Patients With HIV-1 Read More »